Le Lézard
Classified in: Environment, Health, Science and technology
Subjects: SVY, RCY

Scientists Come Up With New Method For Water Supply Facilities Disinfection, NUST MISIS reports


MOSCOW, Nov. 17, 2021 /PRNewswire/ -- Scientists from NUST MISIS and KTH Royal Institute of Technology have developed a new approach to surface disinfection of water supply facilities such as water wells, filters, pipes and reservoirs. They have found that ozone treatment is more effective for the inactivation of viruses and microorganisms than commonly used hypochlorite treatments from corrosion, economic, and environmental perspectives. The study was published in Environmental Science and Pollution Research.

NUST MISIS Logo

At least once a year, drinking water facilities are decontaminated by surface disinfection treatments to inactivate pathogens and microorganisms. The disinfection is commonly carried out using chlorine-containing substances, such as sodium and calcium hypochlorite. A Russian-Swedish research team has found that both sodium and hypochlorite treatments may result in accelerated material degradation, leading to increased corrosion even after the treatment period if disinfectants are trapped in micropores or cracks. Degradation of the inner surface of pipes can, in turn, result in the increase in iron released into tap water, making it unsafe to use for drinking or cooking.

"Ozon is increasingly being used for water decontamination. However, it is rarely used for surface disinfection despite its numerous technological, economic and environmental benefits," noted Valentin Romanovski, Senior Researcher at Research Center for Structural Ceramic Nanomaterials, NUST MISIS.

Scientists from NUST MISIS and KTH Royal Institute of Technology have found that the use of ozone solutions instead of chlorine-based disinfectants significantly lowers the risk of corrosion, resulting in significant reduction in the amount of iron released into tap water. Ozone treatment was proven to have the lowest negative impact on the environment and human health. Another important aspect to consider is the processing time, which in practice means a stop of the drinking water production. If it takes long time and requires handling of chemicals, flushing, and waste effluents, the surface disinfection treatment will be delayed more commonly and is less preferred. Ozone solutions require the shortest time of treatment (30 min) as compared with 6-24 hours for chlorine-based treatments.

Link: https://en.misis.ru/university/news/science/2021-11/7652/

Logo - https://mma.prnewswire.com/media/955872/NUST_MISIS_Logo.jpg


These press releases may also interest you

15 jan 2022
Core One Labs Inc. , , ("Core One" or the "Company") is pleased to announce, as a follow up to the press release dated January 10, that Dr. Robert E.W. Hancock, the Company's Chairman, and CEO of its wholly owned subsidiary Vocan Biotechnologies...

15 jan 2022
Vial announces that in conjunction with the 2022 Winter Clinical Dermatology conference it will host an Advisory Board with leading research sites to discuss the challenges in clinical research with a focus on improving speed and quality of trials in...

15 jan 2022
WHAT: HairClub, with our Miami Heat partner, is donating a once-in-a-lifetime all-inclusive suite night and 200 tickets to a deserving selection of community-driven centers and organizations around South Florida. WHO/WHEN: As part of HairClub's...

15 jan 2022
In the news release, Color Street Foundation Pledges $1M to March of Dimes to Improve Maternal and Infant Health, issued 11-Jan-2022 by Color Street over PR Newswire, we are advised by the company that the "Color Street Foundation" hyperlink in...

15 jan 2022
Zymeworks Inc. , a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today reported, as required by the New York Stock Exchange Listed Company Manual Rule 303A.08 (the "NYSE Rule"), an equity inducement award to Mr....

15 jan 2022
Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced results from a patient satisfaction questionnaire in the long-term, open-label...



News published on 17 november 2021 at 04:00 and distributed by: